TabletSUBCUTANEOUS
🇺🇸United StatesApproved
KEYTRUDA QLEX
Generic Formulation: PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH
SUBCUTANEOUS
Related NDC Products
| NDC Code | Dosage Form | Route | Category |
|---|---|---|---|
| 0006-5083 | INJECTION, SOLUTION | SUBCUTANEOUS | BLA |
| 0006-3026 | INJECTION, SOLUTION | INTRAVENOUS | BLA |
| 0006-3083 | INJECTION, SOLUTION | SUBCUTANEOUS | BLA |